DISCLAIMER
The information and materials accessed through or made available for use on any of our Sites, including, any information about diseases, conditions, treatments, or medicines, are for informational purposes only. The Content is not intended to be and is not a substitute for professional medical advice, diagnosis, or treatment, and your participation on our Sites does not create a healthcare professional-patient relationship. You should consult a doctor or other qualified health care professional regarding any questions you have about your health or before making any decisions related to your health or wellness. Call your doctor or 911 immediately if you think you may have a medical emergency.message sent
email sent successfully
rareLife solutions 606 Post Road East #397 Westport, CT 06880 |
||
You are receiving this because you have an account on www.oneAMYLOIDOSISvoice.com | ||
To unsubscribe from these emails, click here |
Trusted Resources: Community Center
Online support, community stories, financial assistance
Amyloidosis – Wild Type – ATTRwt – wtATTR – Facebook
Amyloidosis – Wild Type – ATTRwt – wtATTR is a Facebook group that was created on 27 June, 2017.
This group is for patients diagnosed with Wild Type Amyloidosis.
Related Content
-
educationNon-Liver Transplant Therapies for ATTR Amyloidosis 2022Non-Liver Transplant Therapies for ATTR ...
-
videos & visualsIntellia CRISPR CAS9 Update – ASG Webinar 11/11https://www.youtube.com/watch?v=K2TmwAfu...
-
videos & visualsATTR in the Heart – ASG Webinar 1/7https://www.youtube.com/watch?v=IzC_yaqs...
-
educationTransthyretin Cardiac Amyloidosis in Older AmericansWild-type transthyretin cardiac amyloido...
-
videos & visualsEidos Clinical Trial Update – ASG Webinar 5/11https://www.youtube.com/watch?v=K2TmwAfu...
-
news & meetingsPortland — Amyloidosis Support Groups Meeting — LIVE — Saturday, April 20, 2024When: Saturday, April 20, 2024 AL wi...
-
news & meetingsFDA Approves Alnylam’s Onpattro for Polyneuropathy of hATTR AmyloidosisThe FDA today granted Alnylam Pharmaceut...
send a message
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.